Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on August 13, 2026.
8.11% of the capital sold short
10 disclosing funds
1,115 disclosures on record
NL0010391025 ISIN code
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 1.59% | new | August 10, 2026 | |
| Walleye Capital LLC | 0.99% | new | August 6, 2026 | |
| Citadel Advisors LLC | 0.90% | +0.32 pt | August 12, 2026 | |
| Marshall Wace LLP | 0.88% | +0.39 pt | August 11, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.80% | -0.05 pt | August 12, 2026 | |
| D. E. Shaw & Co., L.P. | 0.69% | +0.09 pt | August 13, 2026 | |
| Lazard Asset Management LLC | 0.60% | -0.03 pt | August 11, 2026 | |
| Whitebox Advisors LLC | 0.58% | new | June 3, 2026 | |
| Qube Research & Technologies Ltd. | 0.56% | new | August 12, 2026 | |
| Spark Investment Management LLC | 0.52% | new | June 19, 2026 |
On the other side: the funds that hold Pharming Group N.V. Titelia
History of disclosures
Other companies sold short in the Netherlands
- Signify N.V. 10.57% of the capital sold short
- Akzo Nobel N.V. 8.44% of the capital sold short
- The Magnum Ice Cream Company N.V. 6.43% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 3.07% of the capital sold short
- Alfen N.V. 2.27% of the capital sold short
- Shell plc 2.05% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
- Havas N.V. 1.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at August 13, 2026, https://www.quivad.com/action/pharming-group-n-v?page=3